Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Sales (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Return on Sales readings, the most recent being 0.11% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.12%, a 2.0% decrease, with the full-year FY2025 number at 0.12%, down 2.0% from a year prior.
  • Return on Sales hit 0.11% in Q4 2025 for Lucid Diagnostics, down from 0.09% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.04% in Q2 2025 to a low of 1.89% in Q3 2022.
  • Median Return on Sales over the past 5 years was 0.25% (2023), compared with a mean of 0.42%.
  • Biggest five-year swings in Return on Sales: crashed -154bps in 2022 and later soared 171bps in 2023.
  • Lucid Diagnostics' Return on Sales stood at 0.38% in 2021, then crashed by -254bps to 1.33% in 2022, then surged by 92bps to 0.1% in 2023, then increased by 7bps to 0.1% in 2024, then fell by -12bps to 0.11% in 2025.
  • The last three reported values for Return on Sales were 0.11% (Q4 2025), 0.09% (Q3 2025), and 0.04% (Q2 2025) per Business Quant data.